Trazodone and Sleep: A Game-Changer for Opioid Use Disorder?
Episode Overview
Trazodone effectively improves sleep quality in individuals with opioid use disorder maintained on buprenorphine The clinical trial was a randomized double-blind placebo-controlled study with positive outcomes The study population was relatively narrow, limiting direct applicability to diverse patient populations The hosts critically evaluate the trial's validity, recognizing the potential for confident trazodone recommendations in specific patient subsets The findings highlight the medication's potential to address sleep disturbances in addiction medicine practice
So with this data on hand, I really do think I could continue to recommend trazodone confidently as an option for insomnia for patients on buprenorphine.
Can a common antidepressant help those with opioid use disorder sleep better? In this episode of the 'Addiction Medicine Journal Club', Dr. Sonya Del Tredici and Dr. John Keenan dive into a fascinating study on trazodone, a medication often used for sleep disturbances. They explore its impact on patients with opioid use disorder who are maintained on buprenorphine, a common treatment for addiction.
The hosts break down the study's objectives, the patient demographics, and the results, which show promising improvements in sleep quality with minimal side effects. But that’s not all. The episode also touches on the decriminalization of psychedelics and the latest recommendations for managing Hepatitis C in primary care settings. Whether you're a healthcare professional or someone interested in the latest addiction treatment research, this episode offers valuable insights into how trazodone could potentially benefit those struggling with opioid use disorder.
Tune in for an engaging discussion that combines rigorous science with practical applications, making complex topics accessible and relevant.